Make the Diagnosis: This is a Bit …Fishy
(MedPage Today) -- (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - May 10, 2022 Category: Dermatology Source Type: news
In Lupus, 'Normal-Appearing' Skin Is Not Normal
(MedPage Today) -- A fuller picture of how dermal lesions develop in systemic lupus erythematosus (SLE) has been painted by researchers studying patient tissue samples, indicating that "normal-appearing" skin is actually a hotbed of proinflammatory... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - April 28, 2022 Category: Dermatology Source Type: news
FDA OKs New Topical for Inflammatory Rosacea
(MedPage Today) -- The FDA approved benzoyl peroxide 5% cream (Epsolay) for adults with inflammatory lesions of rosacea, Sol-Gel Technologies announced on Monday.
Using silica-based microcapsules that create a barrier between the skin and the... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - April 25, 2022 Category: Dermatology Source Type: news
Some Reassurance on Neurologic Effects of Checkpoint Inhibitors
(MedPage Today) -- Cancer patients treated with immune checkpoint inhibitors (ICIs) had different tradeoffs in neurologic side effects compared with users of other medications, according to a meta-analysis of over three dozen randomized trials... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - April 23, 2022 Category: Dermatology Source Type: news
Intratumoral Combo Shrinks Melanomas Refractory to Anti-PD-1
(MedPage Today) -- Intratumoral injection of an investigational agent, BO-112, combined with pembrolizumab (Keytruda) demonstrated promising efficacy in certain patients with advanced melanoma refractory to anti-PD-1-based therapy, according to... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - April 20, 2022 Category: Dermatology Source Type: news
Dual Immunotherapy Improves PFS in Melanoma Resistant to Anti-PD-1
(MedPage Today) -- NEW ORLEANS -- Nivolumab (Opdivo) plus ipilimumab (Yervoy) improved outcomes compared with ipilimumab alone for patients with advanced melanoma who have primary resistance to PD-1 inhibitors, a randomized study found.
While... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - April 13, 2022 Category: Dermatology Source Type: news
Response in Kids With Psoriasis Maintained Long Term With IL-17A Inhibitor
(MedPage Today) -- Pediatric patients with moderate-to-severe plaque psoriasis obtained significant improvement in disease status for as long as 2 years with the interleukin (IL)-17A inhibitor ixekizumab (Taltz), long-term follow-up from a randomized... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - April 13, 2022 Category: Dermatology Source Type: news
Make the Diagnosis: A Severe Scalp Scene
(MedPage Today) -- (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - April 7, 2022 Category: Dermatology Source Type: news
Smoker's Painless Skin Nodules Flag a Fatal Diagnosis
(MedPage Today) -- Skin metastasis was the first sign for the otherwise asymptomatic patient (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - April 4, 2022 Category: Dermatology Source Type: news
First Topical Therapy for Facial Angiofibroma Nabs FDA Approval
(MedPage Today) -- The FDA approved sirolimus 0.2% gel (Hyftor) as the first topical treatment for facial angiofibroma associated with tuberous sclerosis complex (TSC), Nobelpharma announced.
The approved indication includes patients 6 years or... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - April 4, 2022 Category: Dermatology Source Type: news
Chronic Spontaneous Urticaria Responds Quickly to BTK Inhibitor
(MedPage Today) -- BOSTON -- A form of chronic hives improved quickly and significantly in response to treatment with a novel Bruton's tyrosine kinase (BTK) inhibitor, a multicohort dose-finding study showed.
As many as a fourth of patients... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - March 31, 2022 Category: Dermatology Source Type: news
Psoriasis Therapy Has Mixed Effects on Cardiovascular Risk Factors
(MedPage Today) -- BOSTON -- An evaluation of a common psoriasis drug's effect on one cardiometabolic risk factor instead showed a favorable impact on a different one.
The randomized trial showed that apremilast (Otezla) did not significantly... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - March 30, 2022 Category: Dermatology Source Type: news
Meta-Analysis of Atopic Dermatitis Drugs Favors Two JAK Inhibitors
(MedPage Today) -- Small but statistically significant differences in the safety and efficacy of atopic dermatitis therapies emerged from a systematic review and network meta-analysis of available immunomodulatory options.
Using dupilumab (Dupixent... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - March 30, 2022 Category: Dermatology Source Type: news
Toward More Uniform Methotrexate Dosing in Psoriasis
(MedPage Today) -- With overwhelming support from some 200 experts worldwide, dosing of methotrexate (MTX) for psoriasis should start at 15 mg/week for most adults, though lower in those considered "vulnerable" and in children, according to a new... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - March 30, 2022 Category: Dermatology Source Type: news
Jada Pinkett Smith's Alopecia
(MedPage Today) -- The 2022 Oscars may be noted for its many historic firsts -- including the first deaf man to win an acting Oscar (Troy Kotsur; Best Supporting Actor), among others. Unfortunately, though, the evening may be more likely remembered... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - March 29, 2022 Category: Dermatology Source Type: news
